How a poorly explored immune cell may impact cancer immunity and immunotherapy

20 Nov 2017
Science Daily

The immune cells that are trained to fight off the body's invaders can become defective. It's what allows cancer to develop. So most research has targeted these co-called effector T-cells. But a new study takes a step back and considers: What if the problem isn't with the effector T-cells but starts higher up the cellular chain?

 

Click here to read the 'Science Daily' news article in full